Redhill Biopharma Ltd at Barclays Global Healthcare Conference Transcript
Ladies and gentlemen, welcome to today's RedHill conference call. I would now like to turn the call over to your host, Mr. Prasad. Sir, please go ahead.
Thank you. Good morning, everyone. Thank you for dialing in. My name is Balaji Prasad. I cover specialty pharma for Barclays. So owing to the special circumstances we are in, this is a virtual health care conference and the continuation of day 2 now.
Starting with today's session, we have Dror Ben-Asher, the CEO of RedHill Biopharma, an up-and-coming GI player, which has 3 FDA-approved products officially. This is the recent announcement of the deal with AstraZeneca.
The format will be a presentation from Dror, and there will be no Q&A session owing to this virtual presentation. And at the end of it, of course, RedHill will be hosting one-on-one meetings during the course of the day, virtual one-on-one meetings.
And with that, I invite Dror to take over.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |